Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene

Stem Cell Res. 2016 Sep;17(2):208-211. doi: 10.1016/j.scr.2016.08.015. Epub 2016 Aug 28.

Abstract

Skin fibroblasts were obtained from a male patient diagnosed with retinoblastoma (RB) carrying a c.2663G>A mutation in the 25 exon of RB1 gene. RB-iPS cells was generated via delivered four reprogramming factors (OCT4, SOX2, NANOG and LIN28) into these skin fibroblasts. The RB-iPS cells retained the RB1 heterozygous mutation resulted in a truncated RB1 mRNA. Characteristic tests proved that the iPSC line presented typical markers of pluripotency and had the capability to form the three germ layers in vitro.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Reprogramming*
  • DNA Mutational Analysis
  • Fibroblasts / cytology*
  • Fibroblasts / metabolism
  • Humans
  • Induced Pluripotent Stem Cells / cytology
  • Induced Pluripotent Stem Cells / metabolism*
  • Karyotype
  • Polymorphism, Single Nucleotide
  • Retinoblastoma / genetics
  • Retinoblastoma / metabolism
  • Retinoblastoma / pathology*
  • Retinoblastoma Binding Proteins / genetics*
  • Transcription Factors / genetics
  • Transcription Factors / metabolism
  • Ubiquitin-Protein Ligases / genetics*

Substances

  • RB1 protein, human
  • Retinoblastoma Binding Proteins
  • Transcription Factors
  • Ubiquitin-Protein Ligases